Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
A systematic scorecard-based approach to site assessment in preparation for Lassa fever vaccine clinical trials in affected countries
6
Zitationen
6
Autoren
2020
Jahr
Abstract
It is feasible to hold Lassa fever vaccine trials in affected countries based on the outcome of the survey. However, the findings are to be validated through sites' visits. This experience with a standardized and objective method of the site assessment is encouraging, and the site selection method used can serve as an orientation to sponsors and researchers planning clinical trials in the region.
Ähnliche Arbeiten
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 · 21.183 Zit.
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
2020 · 9.028 Zit.
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
2020 · 4.877 Zit.
The Danger Model: A Renewed Sense of Self
2002 · 4.135 Zit.
How will country-based mitigation measures influence the course of the COVID-19 epidemic?
2020 · 3.883 Zit.